3-methyl-1-oxa-3,7-diazaspiro[4.4]nonan-2-one hydrochloride
95%
- Product Code: 75421
CAS:
1390655-03-4
Molecular Weight: | 192.64 g./mol | Molecular Formula: | C₇H₁₂N₂O₂ClH |
---|---|---|---|
EC Number: | MDL Number: | MFCD26959465 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its unique spirocyclic structure makes it a valuable intermediate in the creation of molecules targeting central nervous system disorders, such as anxiety and depression. Additionally, it has shown potential in the development of treatments for chronic pain and neurodegenerative diseases due to its ability to interact with specific neurotransmitter systems. Researchers also explore its use in designing compounds with improved bioavailability and metabolic stability, enhancing the efficacy of therapeutic agents. Its role in medicinal chemistry continues to expand as new applications in drug discovery are identified.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
1.000 | 10-20 days | Ft472,875.60 |
+
-
|
5.000 | 10-20 days | Ft1,708,989.01 |
+
-
|
3-methyl-1-oxa-3,7-diazaspiro[4.4]nonan-2-one hydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its unique spirocyclic structure makes it a valuable intermediate in the creation of molecules targeting central nervous system disorders, such as anxiety and depression. Additionally, it has shown potential in the development of treatments for chronic pain and neurodegenerative diseases due to its ability to interact with specific neurotransmitter systems. Researchers also explore its use in designing compounds with improved bioavailability and metabolic stability, enhancing the efficacy of therapeutic agents. Its role in medicinal chemistry continues to expand as new applications in drug discovery are identified.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :